Work

Dementia, more than a diagnosis and drugs: perspectives from primary care on the new therapeutic era for Alzheimer’s disease

Year: 2025

Type: article

Abstract: The emergence of anti-amyloid therapies and blood-based biomarkers is transforming the diagnosis and treatment of Alzheimer's disease. In this Viewpoint, as academic primary care physicians, we critically examine how these new diagnostic tools and therapies might drive earlier diagnosis of dementia in primary care and reshape diagnostic pathways, while raising ethical, legal, and social concerns, including high costs, clinical risks, and inequities in access. We explore whether the novel tools will simplify or further complicate the complex clinical reasoning in primary care dementia diagnosis. We emphasise the need to integrate primary care into these new treatment pathways while optimising care for all people with dementia to mitigate worsening health disparities and ensure holistic dementia care, encompassing preventive strategies, post-diagnostic support, early diagnosis, and curative treatments.

Source: The Lancet Primary Care

DOI: 10.1016/j.lanprc.2025.100061

Authors: Tony Foley, Marieke Perry, Dame Louise Robinson

Institutions: University College Cork, Radboud University Medical Center, Newcastle University

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $6,680